Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle

Abstract Background Intramammary (IMM) ceftiofur treatment is commonly used in dairy farms to prevent mastitis, though its impact on the cattle gut microbiome and selection of antibiotic-resistant bacteria has not been elucidated. Herein, we enrolled 40 dairy (Holstein) cows at the end of the lactat...

Full description

Bibliographic Details
Main Authors: Karla A. Vasco, Samantha Carbonell, Rebekah E. Sloup, Bailey Bowcutt, Rita R. Colwell, Karlis Graubics, Ronald Erskine, Bo Norby, Pamela L. Ruegg, Lixin Zhang, Shannon D. Manning
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Animal Microbiome
Subjects:
Online Access:https://doi.org/10.1186/s42523-023-00274-4
_version_ 1827764148026474496
author Karla A. Vasco
Samantha Carbonell
Rebekah E. Sloup
Bailey Bowcutt
Rita R. Colwell
Karlis Graubics
Ronald Erskine
Bo Norby
Pamela L. Ruegg
Lixin Zhang
Shannon D. Manning
author_facet Karla A. Vasco
Samantha Carbonell
Rebekah E. Sloup
Bailey Bowcutt
Rita R. Colwell
Karlis Graubics
Ronald Erskine
Bo Norby
Pamela L. Ruegg
Lixin Zhang
Shannon D. Manning
author_sort Karla A. Vasco
collection DOAJ
description Abstract Background Intramammary (IMM) ceftiofur treatment is commonly used in dairy farms to prevent mastitis, though its impact on the cattle gut microbiome and selection of antibiotic-resistant bacteria has not been elucidated. Herein, we enrolled 40 dairy (Holstein) cows at the end of the lactation phase for dry-cow therapy: 20 were treated with IMM ceftiofur (Spectramast®DC) and a non-antibiotic internal teat sealant (bismuth subnitrate) and 20 (controls) received only bismuth subnitrate. Fecal grab samples were collected before and after treatment (weeks 1, 2, 3, 5, 7, and 9) for bacterial quantification and metagenomic next-generation sequencing. Results Overall, 90% and 24% of the 278 samples had Gram-negative bacteria with resistance to ampicillin and ceftiofur, respectively. Most of the cows treated with ceftiofur did not have an increase in the number of resistant bacteria; however, a subset (25%) shed higher levels of ceftiofur-resistant bacteria for up to 2 weeks post-treatment. At week 5, the antibiotic-treated cows had lower microbiota abundance and richness, whereas a greater abundance of genes encoding extended-spectrum β-lactamases (ESBLs), CfxA, ACI-1, and CMY, was observed at weeks 1, 5 and 9. Moreover, the contig and network analyses detected associations between β-lactam resistance genes and phages, mobile genetic elements, and specific genera. Commensal bacterial populations belonging to Bacteroidetes most commonly possessed ESBL genes followed by members of Enterobacteriaceae. Conclusion This study highlights variable, persistent effects of IMM ceftiofur treatment on the gut microbiome and resistome in dairy cattle. Antibiotic-treated cattle had an increased abundance of specific taxa and genes encoding ESBL production that persisted for 9 weeks. Fecal shedding of ESBL-producing Enterobacteriaceae, which was classified as a serious public health threat, varied across animals. Together, these findings highlight the need for additional studies aimed at identifying factors associated with shedding levels and the dissemination and persistence of antibiotic resistance determinants on dairy farms across geographic locations.
first_indexed 2024-03-11T11:01:38Z
format Article
id doaj.art-debeec842951491fb511162737f818ef
institution Directory Open Access Journal
issn 2524-4671
language English
last_indexed 2024-03-11T11:01:38Z
publishDate 2023-11-01
publisher BMC
record_format Article
series Animal Microbiome
spelling doaj.art-debeec842951491fb511162737f818ef2023-11-12T12:31:01ZengBMCAnimal Microbiome2524-46712023-11-015111910.1186/s42523-023-00274-4Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattleKarla A. Vasco0Samantha Carbonell1Rebekah E. Sloup2Bailey Bowcutt3Rita R. Colwell4Karlis Graubics5Ronald Erskine6Bo Norby7Pamela L. Ruegg8Lixin Zhang9Shannon D. Manning10Department of Microbiology and Molecular Genetics, Michigan State UniversityDepartment of Microbiology and Molecular Genetics, Michigan State UniversityDepartment of Microbiology and Molecular Genetics, Michigan State UniversityDepartment of Microbiology and Molecular Genetics, Michigan State UniversityUniversity of Maryland, Institute for Advanced Computer StudiesCosmos ID, IncDepartment of Large Animal Clinical Sciences, Michigan State UniversityDepartment of Large Animal Clinical Sciences, Michigan State UniversityDepartment of Large Animal Clinical Sciences, Michigan State UniversityDepartment of Microbiology and Molecular Genetics, Michigan State UniversityDepartment of Microbiology and Molecular Genetics, Michigan State UniversityAbstract Background Intramammary (IMM) ceftiofur treatment is commonly used in dairy farms to prevent mastitis, though its impact on the cattle gut microbiome and selection of antibiotic-resistant bacteria has not been elucidated. Herein, we enrolled 40 dairy (Holstein) cows at the end of the lactation phase for dry-cow therapy: 20 were treated with IMM ceftiofur (Spectramast®DC) and a non-antibiotic internal teat sealant (bismuth subnitrate) and 20 (controls) received only bismuth subnitrate. Fecal grab samples were collected before and after treatment (weeks 1, 2, 3, 5, 7, and 9) for bacterial quantification and metagenomic next-generation sequencing. Results Overall, 90% and 24% of the 278 samples had Gram-negative bacteria with resistance to ampicillin and ceftiofur, respectively. Most of the cows treated with ceftiofur did not have an increase in the number of resistant bacteria; however, a subset (25%) shed higher levels of ceftiofur-resistant bacteria for up to 2 weeks post-treatment. At week 5, the antibiotic-treated cows had lower microbiota abundance and richness, whereas a greater abundance of genes encoding extended-spectrum β-lactamases (ESBLs), CfxA, ACI-1, and CMY, was observed at weeks 1, 5 and 9. Moreover, the contig and network analyses detected associations between β-lactam resistance genes and phages, mobile genetic elements, and specific genera. Commensal bacterial populations belonging to Bacteroidetes most commonly possessed ESBL genes followed by members of Enterobacteriaceae. Conclusion This study highlights variable, persistent effects of IMM ceftiofur treatment on the gut microbiome and resistome in dairy cattle. Antibiotic-treated cattle had an increased abundance of specific taxa and genes encoding ESBL production that persisted for 9 weeks. Fecal shedding of ESBL-producing Enterobacteriaceae, which was classified as a serious public health threat, varied across animals. Together, these findings highlight the need for additional studies aimed at identifying factors associated with shedding levels and the dissemination and persistence of antibiotic resistance determinants on dairy farms across geographic locations.https://doi.org/10.1186/s42523-023-00274-4CattleMastitisAntibiotic resistanceMicrobiomeResistomeCeftiofur
spellingShingle Karla A. Vasco
Samantha Carbonell
Rebekah E. Sloup
Bailey Bowcutt
Rita R. Colwell
Karlis Graubics
Ronald Erskine
Bo Norby
Pamela L. Ruegg
Lixin Zhang
Shannon D. Manning
Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle
Animal Microbiome
Cattle
Mastitis
Antibiotic resistance
Microbiome
Resistome
Ceftiofur
title Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle
title_full Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle
title_fullStr Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle
title_full_unstemmed Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle
title_short Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle
title_sort persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle
topic Cattle
Mastitis
Antibiotic resistance
Microbiome
Resistome
Ceftiofur
url https://doi.org/10.1186/s42523-023-00274-4
work_keys_str_mv AT karlaavasco persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle
AT samanthacarbonell persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle
AT rebekahesloup persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle
AT baileybowcutt persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle
AT ritarcolwell persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle
AT karlisgraubics persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle
AT ronalderskine persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle
AT bonorby persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle
AT pamelalruegg persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle
AT lixinzhang persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle
AT shannondmanning persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle